Abstract:Abstract Introduction: Lung cancers demonstrate the highest number of p53 mutations of any cancer with 70% of small cell lung cancers and 33% of adenocarcinomas containing a mutation. Loss of p53 function has been correlated with therapeutic resistance and poor clinical outcomes. Therefore, developing therapeutic strategies that specifically target p53 loss-of-function mutants is of the utmost importance. The purpose of this investigation is to explore whether p53 status has impact on the radio-sensitizing effect of a DNA-PKcs inhibitor (NU7441). Methods: Clonogenic surviving fraction analysis, DNA double strand break repair kinetics, cell cycle analysis, immunofluorescence, immunoblot, apoptosis and autophagy assays were used to investigate the mechanism of radiosensitization of NU7441 in NSCLC cell lines (A549, H1299, and H460) with differential levels of p53 expression. Results: NU7441 substantially inhibited the repair of IR-induced DNA double strand break (DSB) in all three cell lines. Clonogenic surviving fraction analysis reveals that NU7441 is a better radio-sensitizer in p53-deficient cells (H1299) when compared to p53-wild type cells (A549, H460). Combination of ionizing radiation (IR) and NU7441 leads to a more robust G2 arrest in A549 and H460 cells when compared to radiation treatment only. However, NU7441 and radiation preferentially induced mitotic arrest in H1299 consequently leading to a significant increase in mitotic catastrophe. Furthermore, NU7441 led to an increase in apoptosis rather than autophagy as the predominant cell death pathway in p53-deficient cells. Moreover, knockdown of p53 using siRNA sensitized A549 to NU7441+IR treatment. Conclusion: Our study clearly shows that NU7441, a novel DNA-PKcs inhibitor, is a potent radio-sensitizer in p53-dificient lung cancer cells and highlights the promise of NU7441 in targeted cancer treatment. Citation Format: Yu Lan, Zengfu Shang, Feng-Ming Hsu, Vasu Tumati, Benjamin P. Chen, Debabrata Saha. NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 4911. doi:10.1158/1538-7445.AM2014-4911

PNAS-4, an Early DNA Damage Response Gene, Induces S Phase Arrest and Apoptosis by Activating Checkpoint Kinases in Lung Cancer Cells

PNAS-4, a Novel Pro-Apoptotic Gene, Can Potentiate Antineoplastic Effects of Cisplatin

A Novel Pro-Apoptosis Gene Pnas4 That Induces Apoptosis in A549 Human Lung Adenocarcinoma Cells and Inhibits Tumor Growth in Mice

hPNAS-4 inhibits proliferation through S phase arrest and apoptosis: underlying action mechanism in ovarian cancer cells

Genetic transfer of PNAS-4 induces apoptosis and enhances sensitivity to gemcitabine in lung cancer.

Pnas-4 Expression and Its Relationship to P53 in Colorectal Cancer

Improved Therapeutic Efficacy Against Murine Carcinoma By Combining Honokiol With Gene Therapy Of Pnas-4, A Novel Pro-Apoptotic Gene

Altered Protein-Expressing Profile in Hpnas4-Induced Apoptosis in A549 Human Lung Adenocarcinoma Cells

Integrated High Throughput Analysis Identifies GSK3 As a Crucial Determinant of P53-Mediated Apoptosis in Lung Cancer Cells

Mitosis Targeting in Non-Small Lung Cancer Cells by Inhibition of PAD4

Abstract 4911: NSCLC Cells Demonstrate Differential Mode of Cell Death in Response to the Combined Treatment of Radiation and a DNA-PKcs Inhibitor

NME4 May Enhance Non‑small Cell Lung Cancer Progression by Overcoming Cell Cycle Arrest and Promoting Cellular Proliferation.

Research Progress of a Novel Pro-apoptosis Gene PNAS-4 in Gene Therapy and Its Molecular Mechanism Hypotheses

Efficient Inhibition of Ovarian Cancer Growth and Prolonged Survival by Transfection with a Novel Pro-Apoptotic Gene, hPNAS-4, in a Mouse Model

Inhibition of DNA‑PK Activity Sensitizes A549 Cells to X‑ray Irradiation by Inducing the ATM‑dependent DNA Damage Response

Upregulation Of Cleavage And Polyadenylation Specific Factor 4 In Lung Adenocarcinoma And Its Critical Role For Cancer Cell Survival And Proliferation

Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer

NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor.

PNAS-2: a novel gene probably participating in leukemogenesis.

Antitumor Effects of PLGA Nanoparticles Encapsulating the Human PNAS-4 Gene Combined with Cisplatin in Ovarian Cancer.

G4-Tetra DNA Duplex Induce Lung Cancer Cell Apoptosis in A549 Cells